BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6334509)

  • 1. Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities.
    Pahl MV; Vaziri ND; Saiki JK; Upham T; Ness R
    Artif Organs; 1984 Nov; 8(4):423-8. PubMed ID: 6334509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent lupus activity in end-stage renal disease.
    Krane NK; Burjak K; Archie M; O'donovan R
    Am J Kidney Dis; 1999 May; 33(5):872-9. PubMed ID: 10213642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of lupus activity in end-stage renal disease treated by hemodialysis.
    Okano K; Yumura W; Nitta K; Uchida K; Ohnuki T; Kawashima A; Nihei H
    Intern Med; 2001 Jul; 40(7):598-602. PubMed ID: 11506299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients.
    Lee PT; Fang HC; Chen CL; Chiou YH; Chou KJ; Chung HM
    Lupus; 2003; 12(11):827-32. PubMed ID: 14667098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between antibodies to dsDNA and to soluble cellular antigens and histologically defined glomerulonephritis in patients with SLE.
    Asero R; Banfi G; Radelli L; Origgi L; Bertetti E; Vanoli M; Riboldi P
    Autoimmunity; 1990; 7(1):13-21. PubMed ID: 2103306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of systemic lupus erythematosus in a male patient after 14 years on hemodialysis.
    Al-Hawas F; Abdalla AH; Al-Sulaiman MH; Mousa DH; Owda AK; Al-Khader AA
    Am J Kidney Dis; 1997 Apr; 29(4):631-2. PubMed ID: 9100057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of lupus nephritis.
    Grünfeld JP; Araujo A; Droz D; Tron F; Jungers P
    Contrib Nephrol; 1984; 43():12-24. PubMed ID: 6386322
    [No Abstract]   [Full Text] [Related]  

  • 11. End-stage renal failure in systemic lupus erythematosus with nephritis.
    Correia P; Cameron JS; Ogg CS; Williams DG; Bewick M; Hicks JA
    Clin Nephrol; 1984 Dec; 22(6):293-302. PubMed ID: 6396007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature.
    Mattos P; Santiago MB
    Clin Rheumatol; 2012 Jun; 31(6):897-905. PubMed ID: 22415467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE.
    Nossent HC; Swaak TJ; Berden JH
    Am J Med; 1990 Aug; 89(2):169-74. PubMed ID: 2382665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.
    Plantinga LC; Lim SS; Patzer RE; Pastan SO; Drenkard C
    BMC Nephrol; 2016 Jul; 17(1):64. PubMed ID: 27388761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares.
    Sires RL; Adler SG; Louie JS; Cohen AH
    Am J Nephrol; 1989; 9(4):279-84. PubMed ID: 2817017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus in patients with chronic renal failure.
    Cheigh JS; Stenzel KH; Rubin AL; Chami J; Sullivan JF
    Am J Med; 1983 Oct; 75(4):602-6. PubMed ID: 6353915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis on end-stage lupus nephritis.
    Coplon N; Siegel R; Fries J
    Trans Am Soc Artif Intern Organs; 1973; 19():302-4. PubMed ID: 4579028
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort.
    Ribeiro FM; Leite MA; Velarde GC; Fabris CL; Santos RC; Lugon JR
    Am J Nephrol; 2005; 25(6):596-603. PubMed ID: 16282677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis.
    Stock GG; Krane NK
    Adv Perit Dial; 1993; 9():147-51. PubMed ID: 8105910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosus.
    Fisher C; Gibb WR; Cohen SL; Collins CR; Potter A; Isenberg DA
    Br J Rheumatol; 1985 Aug; 24(3):256-62. PubMed ID: 3874672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.